News

Degenerative Disc Disease Pipeline 2025: Mechanism of Action, Route of Administration, and Clinical Trial Insights Explored by DelveInsight | Mesoblast, DiscGenics, Biosplice Therapeutics, BIOPHARM ...
According to Credence Research, the global Spine Degenerative Disk Disease Treatment Market was valued at USD 22,272.2 ...
The field of gerontology is witnessing a significant demographic transition, as the global population of individuals aged 65 ...
By Joi Fultz Click here for updates on this story RICHMOND, Virginia (WTVR) — Dozens of people have contacted CBS 6 offering to help a 70-year-old woman with a degenerative disc disease who ...
Degenerative disc disease (DDD) and intervertebral disc degeneration (IVDD) represent conditions that impair the function of the spinal motion segments, profoundly affecting quality of life worldwide.
"FDA approves Dymicron’s study of cervical artificial disc" was originally created and published by Medical Device Network, a ...
A new study published in the journal of Arthritis Care and Research revelaed that metabolic syndrome is associated with ...
HOUSTON, July 09, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeuti ...
Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United ...
Dymicron’s Triadyme-C artificial disc earned the FDA’s investigational device exemption approval, according to a July 10 news release. The IDE approval opens the door for a U.S. trial of the disc, ...
RICHMOND, Virginia (WTVR) — Dozens of people have contacted CBS 6 offering to help a 70-year-old woman with a degenerative disc disease who needs assistance picking up a motorized wheelchair ...